These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21946060)

  • 1. Fetal hypoxia and programming of matrix metalloproteinases.
    Tong W; Zhang L
    Drug Discov Today; 2012 Feb; 17(3-4):124-34. PubMed ID: 21946060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal hypoxia alters matrix metalloproteinase expression patterns and causes cardiac remodeling in fetal and neonatal rats.
    Tong W; Xue Q; Li Y; Zhang L
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2113-21. PubMed ID: 21856922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TIMPs tango with MMPs and more in the central nervous system.
    Crocker SJ; Pagenstecher A; Campbell IL
    J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their tissue inhibitors in hypertension-related pregnancy complications.
    Karthikeyan VJ; Lane DA; Beevers DG; Lip GY; Blann AD
    J Hum Hypertens; 2013 Feb; 27(2):72-8. PubMed ID: 22418748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.
    Moore L; Fan D; Basu R; Kandalam V; Kassiri Z
    Heart Fail Rev; 2012 Sep; 17(4-5):693-706. PubMed ID: 21717224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury.
    Park SY; Shin HW; Lee KB; Lee MJ; Jang JJ
    J Korean Med Sci; 2010 Apr; 25(4):570-6. PubMed ID: 20358000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.
    Parrish AR
    Prog Mol Biol Transl Sci; 2017; 148():31-65. PubMed ID: 28662825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
    Séguier S; Gogly B; Bodineau A; Godeau G; Brousse N
    J Periodontol; 2001 Oct; 72(10):1398-406. PubMed ID: 11699482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
    Groblewska M; Siewko M; Mroczko B; Szmitkowski M
    Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
    Mroczko B; Groblewska M; Barcikowska M
    J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and atherosclerosis.
    Watanabe N; Ikeda U
    Curr Atheroscler Rep; 2004 Mar; 6(2):112-20. PubMed ID: 15023295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors.
    Snoek-van Beurden PA; Von den Hoff JW
    Biotechniques; 2005 Jan; 38(1):73-83. PubMed ID: 15679089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents.
    Corporan D; Onohara D; Hernandez-Merlo R; Sielicka A; Padala M
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1269-H1278. PubMed ID: 30141979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinases (MMPs) and Inhibitors of MMPs in the Avian Reproductive System: An Overview.
    Hrabia A
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of collagens, HSP47, TGF-beta1, MMPs and TIMPs in epidermolysis bullosa acquisita.
    Razzaque MS; Kumari S; Foster CS; Ahmed AR
    Cytokine; 2003 Mar; 21(5):207-13. PubMed ID: 12824005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.